/ Download pdf version of this article
Most GPs provided correct answers for questions 1, 2 and 3, however there still seems to be a need
for clarity regarding indications for hydrolysed and partially-hydrolysed formula.
It appears that soy-based formula is less favoured than it has been in the past. Negative publicity about other substances
contained in soy formula may have altered perceptions about its appropriateness.
Cows’ milk protein allergy is the most common food allergy in early childhood with an incidence
of approximately 2-3% in the first year of life. Symptoms typically develop before one month of age, often within one
week after introduction of cows’ milk-based formula. Cows’ milk allergy can also occur in exclusively breastfed
infants mostly due to the transfer of cows’ milk protein from the nursing mother’s diet. Hydrolysed infant
formulas have been designed to change the allergenic milk protein with the aim of preventing sensitisation or intolerance.
They may be produced from cows’ milk or soy milk, be derived from predominately whey or casein proteins and be partially
or extensively hydrolysed. For non-breastfed infants, extensively hydrolysed formula (e.g. Pepti-Junior)
is recommended for treating immediate cows’ milk allergy (non-anaphylactic). Partially hydrolysed cows’ milk
based formula (e.g. Nestle NAN HA 1) contains peptides large enough to cause allergic reactions to cows’ milk
protein and is not suitable for treatment. These partially hydrolysed formulas have been marketed for high-risk infants
before any signs of cows’ milk allergy appear yet evidence regarding its prophylactic use is limited. Further large,
well-designed trials are needed.
Although studies have confirmed that soy and goats’ milk formula are adequate for promoting normal growth and
development in full-term infants, there are few indications for their use in place of cows’ milk based formula.
Goats’ milk formula is not a suitable alternative for babies who are allergic to cows’ milk
protein as the vast majority of these infants will also suffer an allergic reaction to goats’ milk, as the proteins
in the milks are quite similar. Goats’ milk formula is also unsuitable for babies who are lactose intolerant as
it contains comparable levels of lactose to cows’ milk based infant formulas. Goats’ milk infant formula has
been available in New Zealand for routine use for over 15 years. It is available at similar cost to soy formulas, and
is typically 20-50% more expensive than standard cow milk-based formulas. In New Zealand the use of goats milk formulas
comprise approximately 5% of infant formula purchased.1
Soy formula were originally developed for infants who could not tolerate cows’ milk protein or
lactose. Current evidence indicates that nearly 50% of children with cows’ milk allergy will also have adverse reactions
to soy. Furthermore soy formula is not required for lactose intolerance as there is no need to eliminate milk protein.
Indications for the use of soy formulas in place of cow milk-based formulas are as follows: (a) for infants with galactosaemia
when strict dietary lactose elimination is required or primary lactase deficiency (rare), and (b) for infants of vegetarian
families who may want to exclude animal proteins in their child’s diet. Soy protein-based formulas with sucrose
as the carbohydrate are contraindicated in sucrase-isomaltase deficiency and in hereditary fructose intolerance.
One of the most common reasons for use of soy formulas by infant care providers is for relief of perceived formula intolerance
(spitting, vomiting, fussiness) or symptoms of infantile colic. Controlled trials of cows’ milk and soy protein-based
formulas have not yet proven beneficial in the prevention or management of colic or fussiness. Theoretical concerns surrounding
the high levels of soy phytoestrogens have prompted investigations on the possible adverse effect of these factors in
soy formulas. Although very limited data suggests that soy phytoestrogens have a low affinity for human estrogen receptors,
they have not demonstrated to have any adverse affect on human development, reproduction, or endocrine function.2
Lactose free and reduced lactose-containing cows’ milk formula are appropriate for use in lactose
The nutritional management of diabetes
It appears that the concept of glycaemic index versus glycaemic load is still not well understood, with only 64% of
GPs correctly identifying that watermelon is a low glycaemic load food (question 4).
Glycemic index (GI) was introduced nearly 30 years ago in an attempt to classify carbohydrate-rich
foods on the basis of their effect on postprandial blood glucose. Since blood glucose is also influenced by the amount
of carbohydrate consumed, the concept of glycemic load (GL) was introduced to better represent the impact
of both the quality (GI) and quantity of the carbohydrate ingested. By definition, foods that have a low GI invariably
have a low GL, while foods with a medium or high GI can range from a very low to very high GL. It has been suggested that
dietary GL provides little information beyond total carbohydrate intake. In contrast, dietary GI, which does not reflect
total carbohydrate intake, is thought to provide limited information with regards to the overall insulin demand induced
by total carbohydrate intake. Therefore, if the GI or GL is to be used, it should be in consideration with other relevant
characteristics of the food such as energy content, amount of fat and dietary fibre. Although there is disagreement in
the literature concerning the use of the GI in the prevention and management of diabetes, most would agree that GI could
be used as a helpful indicator of appropriate carbohydrate-containing foods to include more often in the diet.3,4
The nutritional management of weight loss in COPD
GP feedback tells us that the use of supplements such as Pulmocare in COPD is not widespread. However in question
5, 22% of respondents indicated that they would use this supplement to minimise breathing difficulties. The
indications for the use of Pulmocare in patients with COPD are quite limited and include patients with a low BMI, significant
involuntary weight loss and those who develop hypercapnia. Our advice would be to promote dietary changes that encourage
small, frequent, high energy and high protein diets, generally with advice from a dietitian. Indications for nutritional
supplements for people with COPD were correctly identified by most respondents in question 6.
Malnutrition commonly occurs in patients with COPD. Nutritional management can be complicated as eating may increase
the respiratory quotient (RQ) (ratio of CO2 produced to O2 consumed) and increase the work of breathing.
The RQ produced from the metabolism of carbohydrate, fat and protein is 1.0, 0.7, and 0.8, respectively. Therefore, for
a given amount of oxygen consumed, more carbon dioxide is produced from the metabolism of carbohydrate than from fat or
protein. The primary goal of nutritional support is to adopt a strategy that corrects the malnutrition without increasing
the RQ. Pulmocare is a high-calorie, low-carbohydrate formula designed to help reduce CO2 production. Fat replaces
carbohydrate as the major source of calories and thus, consumption of this formula potentially decreases CO2 retention.
Further, 20% of fat is provided as medium chain triglycerides to enhance fat absorption. One study demonstrated that consumption
of Pulmocare when used as a nutritional supplement resulted in significantly lower RQ, CO2 production and O2 consumption
as compared to a group of patients consuming a high-carbohydrate diet.5
Nutrition in elderly people
A good understanding of nutrition for elderly people was reflected in answers for questions 7 and 8,
however GPs tell us that there is often a discrepancy between what should be done and the reality of what can be done.
There are many interwoven reasons for poor nutrition and it can often be difficult for people to change. GPs are familiar
with giving advice about reducing the energy and calorific content of meals and there are many resources available to
reinforce this, however it is more difficult to provide information for when appetite and nutrition are poor.
Advocating access to day programmes, often run by rest homes or community organisations, where lunch and social contact
was provided is a solution used by some GPs. Other tips for dealing with poor appetite included encouraging people to
choose their favourite foods, having small attractively presented meals and promoting the value of company while eating.
Anxiety should be considered as both a cause and a consequence of poor nutrition.
Evidence for the effectiveness of nutritional supplements prescribed to improve the nutritional status of older people
is limited. Recent systematic reviews of oral protein and energy supplementation in older people at risk from malnutrition
suggested a small but consistent weight gain.6,7 Early screening for the risk or presence of malnutrition and
implementation of early nutritional care programmes demonstrate improved outcomes.8
Vitamins and minerals
GPs are very familiar with the fact that folic acid is required during pregnancy (question 9), but
they say that the message of pre-conceptual use of folic acid is still not well known in the general population and that
in the majority of cases, women tend to present when they are already pregnant rather than for pre-conceptual counselling.
Wider dissemination of information is required to encourage pre-conceptual use of folic acid.
It was not well known that pregnant women are also at risk of vitamin B12 deficiency (question 10).
The need for iodine supplementation in pregnancy may also be new information for some GPs.
Iodine requirements increase during pregnancy to ensure maternal thyroid hormone (T4) production can
be maintained at almost double that of the non-pregnant state. Studies of pregnant women conducted in New Zealand suggest
ongoing, and even worsening, iodine deficiency in this group.9,10 It should be noted that not all multivitamin
supplements available for pregnant and lactating women contain iodine (e.g. Elevit). There are no oral iodine preparations
available as registered medicines in New Zealand. By September 2009, mandatory fortification of bread by means of replacing
non-iodised salt with iodised will serve to increase the daily iodine intakes of adults by about 30-70 micrograms. There
are concerns that the current fortification programme will not provide the adequate intake levels for pregnant and lactating
women (RDI of 220 and 270 micrograms, respectively).
Beyond folate deficiency, current data suggest that maternal vitamin B12 deficiency may be associated
with an increased risk for neural tube defects. A study in Canada recently revealed that about 1 in 20 women may be deficient
in B12 in early pregnancy.11 In the study, the rate of vitamin B12 deficiency nearly doubled after 28 days
gestation, which the researchers highlight may be due to the known hemodilutional effect of pregnancy. Vitamin B12 deficiency
during pregnancy may also contribute to deficiency in the foetus and infant, and lead to preterm delivery. The full implications
of starting pregnancy and lactation with low vitamin B12 status have not been sufficiently researched.
The achievement of an optimal vitamin B12 status is difficult for many older people due to age-related decreases in
gastric acid production, which may prevent the release of B12 from food. Long-established as a rare but serious medical
condition requiring medical management, vitamin B12 deficiency is now seen to be common worldwide, albeit subclinical
in nature.12 The prevalence has been dramatically increased by also including persons with “low-normal” vitamin
B12 levels. One study estimated that as many as 10% and 20% of British people aged 65-74 and greater than 75 years, respectively
were at high risk of vitamin B12 deficiency.13 Theoretically, older people with mild vitamin B12 deficiency
should be able to absorb free (crystalline) vitamin B12 found in fortified foods and supplements. The high prevalence
of low vitamin B12 status among older adults, and treatment therefore is an important public health issue that requires
further investigation. Studies are needed to define the still unproven health benefits of vitamin B12 fortification, the
optimal levels of supplementation, interactions with other nutrients, and any possible adverse effects on healthy persons.